These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14533441)

  • 1. Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer.
    Dabrow MB; Francesco MR; Gilman PB; Cantor R; Rose L; Meyer TJ
    Cancer Invest; 2003; 21(4):517-25. PubMed ID: 14533441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer.
    Guarino MJ; Schneider CJ; Grubbs SS; Biggs DD; Himelstein AL; Hogaboom K; Tilak S
    Oncologist; 2002; 7(6):509-15. PubMed ID: 12490738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.
    Thomas P; Robinet G; Ferri-Dessens RM; Léna H; Gouva S; Vernejoux JM; Kleisbauer JP
    Lung Cancer; 2002 May; 36(2):191-8. PubMed ID: 11955654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.
    Bidoli P; Stani SC; Mariani L; De Candis D; Cortinovis D; Aglione S; Zilembo N; Toffolatti L; Formisano B; Bajetta E
    Lung Cancer; 2004 Feb; 43(2):203-8. PubMed ID: 14739041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3).
    Rinaldi D; Lormand N; Brierre J; Cole J; Barnes B; Fontenot F; Buller E; Rainey J
    Cancer Invest; 2001; 19(5):467-74. PubMed ID: 11458814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and pharmacologic study of weekly bolus topotecan for advanced non-small-cell lung cancer.
    Masuda N; Matsui K; Negoro S; Takeda K; Kudoh S; Nakagawa K; Mukaiyama A; Arase H; Yoshida P; Ijima T; Takada M; Fukuoka M
    Clin Lung Cancer; 2010 Jul; 11(4):271-9. PubMed ID: 20630830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer.
    Artal-Cortés A; Martínez-Trufero J; Herrero A; Puértolas T; Alonso V; Corral M; Ceballos C; Maurel J; Antón A
    Anticancer Drugs; 2003 Feb; 14(2):111-8. PubMed ID: 12569297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study.
    Stathopoulos GP; Rigatos SK; Christodoulou C; Malamos NA; Deliyiannis F; Stathopoulos JG; Skarlos DV
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):259-64. PubMed ID: 15127231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma.
    Bourgeois H; Billiart I; Chabrun V; Chieze S; Lemerre D; Germain T; Ferrand V; Meurice JC; Daban A; Tourani JM
    Am J Clin Oncol; 2004 Feb; 27(1):89-95. PubMed ID: 14758140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer.
    Esteban E; Fra J; Corral N; Valle M; Carrasco J; Sala M; Puerta J; Estrada E; Palacio I; Vieitez JM; Buesa JM; Lacave AJ
    Invest New Drugs; 2002 Feb; 20(1):73-82. PubMed ID: 12003196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.
    Athanasiadis A; Roussos G; Papakostoulis T; Athanasiadou DC; Stathopoulos GP
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):653-8. PubMed ID: 15937714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).
    Favaretto A; Ceresoli GL; Paccagnella A; Barbieri F; Bearz A; Ghiotto C; Oniga F; Schiavon S; Frustaci S; Villa E
    Ann Oncol; 2000 Nov; 11(11):1421-6. PubMed ID: 11142482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer.
    Gillenwater HH; Stinchcombe TE; Qaqish BF; Tyann M; Hensing TA; Socinski MA
    Lung Cancer; 2005 Mar; 47(3):413-9. PubMed ID: 15713525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer].
    Ryo H; Toyama K; Isobe K; Sugino K; Sano G; Yamada H; Hiroi M; Hojyo T; Kimura K
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):237-42. PubMed ID: 12610872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.
    Kakolyris SS; Kouroussis C; Koukourakis M; Kalbakis K; Mavroudis D; Vardakis N; Georgoulias V
    Anticancer Res; 2002; 22(3):1891-6. PubMed ID: 12168889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.
    Nemunaitis J; Cunningham CC; Vukelja S; Ruxer RL; Adams N; Rich D; Paulson AS; MacEachern JB
    Cancer Invest; 2004; 22(3):360-7. PubMed ID: 15493356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V; Crucitta E; Panza N; Silvestris N; Guida M; Carpagnano F; Mancarella S; Sambiasi D; De Lena M
    Ann Oncol; 2002 Dec; 13(12):1862-7. PubMed ID: 12453853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
    Iaffaioli RV; Tortoriello A; Facchini G; Caponigro F; Gentile M; Marzano N; Gravina A; Dimitri P; Costagliola G; Ferraro A; Ferrante G; De Marino V; Illiano A
    J Clin Oncol; 1999 Mar; 17(3):921-6. PubMed ID: 10071285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study.
    Syrios J; Kouroussis C; Kotsakis A; Kentepozidis N; Kontopodis E; Kalbakis K; Vardakis N; Hatzidaki D; Polyzos A; Georgoulias V;
    Minerva Ginecol; 2019 Jun; 71(3):182-190. PubMed ID: 30727721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.